about-me variable
Life Science Access Academy Ltd invites you to their event

July Think Tank - Optimising outcomes for NICE assessment of new medicines

About this event

Ian Chamberlain hosts July’s Think Tank where he'll discuss the optimising of outcomes for NICE assessment of new medicines.

For this 60-minute live event, Ian will be joined by three leading industry experts, Neil Grubert, Eric Low and Henry Burkitt.

Neil Grubert is a multilingual pharmaceutical market access specialist with 30 years of experience tracking the global prescription drug and self-medication markets. He is the author of more than 150 reports covering 20 mature and emerging markets, multiple therapeutic areas and numerous industry issues, and has earned a reputation for his extensive knowledge of market access environments around the world.

Eric Low is the founder of Eric Low Consulting, he specialises in strategic market access, patient engagement, and life sciences and healthcare policy. Prior to founding his consultancy business, Eric established and served for 20 years as CEO of, Myeloma UK (Edinburgh, UK) – an organisation credited with ensuring that myeloma patients in the UK can access novel treatments by advocating for solution- oriented approaches to the way drugs are made available on the NHS.

Henry Burkitt is the founder of Oxygen - a strategic healthcare public affairs company whose services include healthcare strategy development, public affairs consultancy, market access support and stakeholder relations.

Together, they will discuss the myths surrounding market access NICE / HTA submissions followed by a Q&A session.

By attending the session you’ll take away information surrounding:

  • What pharma gets wrong – and what it can do about it
  • What role government affairs play in an affective submission
  • How to build advocacy for a competitive edge
  • How to best integrate patients’ needs and voice into a submission


Sign up today!

Hosted by

  • Guest speaker
    G
    Henry Burkitt Oxygen Strategy @ Founder

    I am the founder of Oxygen - a strategic healthcare public affairs company based in the new diplomatic precinct of Nine Elms in London. Oxygen is a growing team of healthcare policy experts with a proven track-record in developing tangible outcomes for clients. Our services include healthcare strategy development, public affairs consultancy, market access support and stakeholder relations. We deliver precise and laser-sharp insight, cutting through to diagnose and deliver results, from management level to the boardroom. Our combination of creative disruption and extensive knowledge helps deliver efficient, clear and concise results. Our team is dedicated to policy outcomes which benefit every part of society. It’s why our vision is to make a difference, not just a profit.

  • Guest speaker
    G
    Eric Low Eric Low Consulting @ Founder

    Eric Low is the Founder of Eric Low Consulting (Edinburgh, UK). In his current consultancy position, Low specialises in strategic market access, patient engagement, and life sciences and healthcare policy. Prior to founding his consultancy business, Low established, and served for 20 years as CEO of, Myeloma UK (Edinburgh, UK) – an organisation credited with ensuring that myeloma patients in the UK can access novel treatments by advocating for solution-oriented approaches to the way drugs are made available on the NHS. Low is also a Senior Visiting Research Fellow at the University of Leeds Medical School (Leeds, UK) and was awarded an OBE for services to charity in 2012.

  • Guest speaker
    G
    Neil Grubert

    A pharmaceutical market access specialist with more than 20 years’ experience of tracking access environments around the world. He advises leading biopharmaceutical companies on the implications of international access trends and has authored more than 150 reports in the field. He also delivers multi-client and bespoke training programmes.

  • Team member
    T
    Ian Chamberlain Managing Director @ Life Science Access Academy

    Ian co-founded the Life Science Access Academy with Nigel Robbins to bring together all the best ideas in people development from more than 20 innovative specialist consultancies.

Life Science Access Academy Ltd

LSAA is a truly Global Membership Community for all staff from across the Life Science sector including: commercial, clinical and financial sales teams, medics and support teams.